Journal of Infectious Diseases & Preventive Medicine
Open Access
ISSN: 2329-8731
ISSN: 2329-8731
Marcy Hernick, PhD, NIH
Department of Biochemistry
Virginia Tech, Blacksburg, USA
Dr. Marcy Hernick is currently an Assistant Professor in the Biochemistry Department at Virginia Tech. Dr. Hernick received her B.S. in Pharmacy from Albany College of Pharmacy in Albany, NY in 1998. She earned her Ph. D in Medicinal Chemistry from Purdue University, Department of Medicinal Chemistry and Molecular Pharmacology in 2002 for her work on the design, synthesis, mechanisms of activation and biological activity of indoloquinone phosphoramidate prodrugs. Dr. Hernick completed her postdoctoral studies at the University of Michigan Chemistry Department, where she studied the enzyme mechanism and molecular recognition properties of the metalloenzyme LpxC deacetylase. Dr. Hernick assumed her current position at Virginia Tech in 2007 where her research is focused on inositol metabolism in Mycobacterium species.
Dr. Marcy Hernick is currently an Assistant Professor in the Biochemistry Department at Virginia Tech. Dr. Hernick received her B.S. in Pharmacy from Albany College of Pharmacy in Albany, NY in 1998. She earned her Ph. D in Medicinal Chemistry from Purdue University, Department of Medicinal Chemistry and Molecular Pharmacology in 2002 for her work on the design, synthesis, mechanisms of activation and biological activity of indoloquinone phosphoramidate prodrugs. Dr. Hernick completed her postdoctoral studies at the University of Michigan Chemistry Department, where she studied the enzyme mechanism and molecular recognition properties of the metalloenzyme LpxC deacetylase. Dr. Hernick assumed her current position at Virginia Tech in 2007 where her research is focused on inositol metabolism in Mycobacterium species.